RxDoctor Payments Data

Sasha Griffin

Psychiatric/Mental Health · Orlando, FLNPI 1942431184

Payments from drug & device makers

$5,693in general payments, 2019–2025

Across 190 payments — averaging $29.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Neurocrine Biosciences, Inc.$2K
  • AbbVie$757
  • Corium, LLC$293
  • Neos Therapeutics, LP$288
  • Johnson & Johnson$273
  • Takeda Pharmaceuticals U.S.A., Inc.$182
  • plus $2K from 21 others
$1,554in research payments, 2019–2025

Across 7 payments — averaging $222.07 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • AbbVie$2K

What the payments were for

  • Travel & lodging$1,45826%
  • Food & beverage$4,20774%
  • Education$270%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,693 in reported general payments places this provider in the 90th percentile of 3,096 psychiatric/mental health providers in Florida.

See all psychiatric/mental health providers in Florida

Other psychiatric/mental health in Orlando

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →